Home
Members
Education
News & Events
Publications
Fundraising
- Donation Rationale
- How to Donate
About

Diagnosis and management of childhood polycystic kidney disease

Thu, May 5, 2011

Management of toxic ingestions with the use of renal replacement therapy

Thu, May 5, 2011

Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy

Thu, May 5, 2011

A major cellular receptor in human Shiga toxin HUS is called

a. crry
b. Gb3
c. CD42
d. MCP
e. Factor I

The predominant pathway that is affected by atypical HUS is the

a. VEGF-A pathway
b. Lectin complement pathway
c. Alternative complement pathway
d. Classical complement pathway
e. Coagulation pathway

Which of the following are solid phase complement components?

a. Factor H
b. Factor I
c. MCP
d. C3
e. C4

After renal transplantation, in which of the following is there least likely to be a recurrence of HUS in the transplanted kidney?

a. Factor H mutations
b. Factor I mutations
c. C3 mutations
d. MCP mutations
e. Thrombomodulin mutations

The cause of pneumococcal-induced HUS is thought to be

a. Alterations in podocyte-derived VEGF-A
b. Abnormalities in the classical complement pathway
c. Thromboxane hyper-stimulation
d. Exposure of neuraminidase on the cell surfaces
e. Production of neuraminidase by the bacteria exposing the TF antigen

Event Calendar

May 2011
M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	EC

Search

© 2013 International Pediatric Nephrology Association | Sitemap